Financhill
Buy
65

CWAN Quote, Financials, Valuation and Earnings

Last price:
$24.16
Seasonality move :
-9.55%
Day range:
$24.07 - $24.12
52-week range:
$15.74 - $32.00
Dividend yield:
0%
P/E ratio:
15.77x
P/S ratio:
10.01x
P/B ratio:
3.57x
Volume:
4.4M
Avg. volume:
10.8M
1-year change:
-12.35%
Market cap:
$7.1B
Revenue:
$451.8M
EPS (TTM):
$1.53

Analysts' Opinion

  • Consensus Rating
    Clearwater Analytics Holdings, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 5 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $27.89, Clearwater Analytics Holdings, Inc. has an estimated upside of 15.62% from its current price of $24.12.
  • Price Target Downside
    According to analysts, the lowest downside price target is $24.00 representing 100% downside risk from its current price of $24.12.

Fair Value

  • According to the consensus of 7 analysts, Clearwater Analytics Holdings, Inc. has 15.62% upside to fair value with a price target of $27.89 per share.

CWAN vs. S&P 500

  • Over the past 5 trading days, Clearwater Analytics Holdings, Inc. has overperformed the S&P 500 by 1.32% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Clearwater Analytics Holdings, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Clearwater Analytics Holdings, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Clearwater Analytics Holdings, Inc. reported revenues of $205.1M.

Earnings Growth

  • Clearwater Analytics Holdings, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Clearwater Analytics Holdings, Inc. reported earnings per share of -$0.04.
Enterprise value:
7.9B
EV / Invested capital:
--
Price / LTM sales:
10.01x
EV / EBIT:
317.40x
EV / Revenue:
12.35x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
96.70x
Price / Operating cash flow:
78.36x
Enterprise value / EBITDA:
93.69x
Gross Profit (TTM):
$438.2M
Return On Assets:
21.59%
Net Income Margin (TTM):
61.3%
Return On Equity:
29.67%
Return On Invested Capital:
22.72%
Operating Margin:
3.46%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $351.8M $424.4M $640.4M $115.8M $205.1M
Gross Profit $249.5M $306.1M $438.2M $84.5M $134.5M
Operating Income -$15.5M $15.5M $24.9M $7.6M $7.1M
EBITDA $783K $26.9M $84.4M $10.8M $36.4M
Diluted EPS -$0.12 $0.00 $1.53 $0.02 -$0.04
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $302M $369.3M $397M $426.1M $246.7M
Total Assets $326.6M $419.7M $535.5M $623.5M $3B
Current Liabilities $32.3M $35.6M $63.1M $92.4M $127.6M
Total Liabilities $84.2M $109.5M $144.1M $169.8M $989M
Total Equity $242.4M $310.3M $391.4M $453.6M $2B
Total Debt $54.6M $69.3M $66.9M $65.7M $867.3M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $78.7M $127.6M $91.4M $49.6M $49M
Cash From Investing -$163.3M -$54.2M -$989.3M -$1M -$4.1M
Cash From Financing $836K -$51.9M $731M -$10.9M -$51.4M
Free Cash Flow $72.7M $121.6M $81.8M $48.1M $44.9M
CWAN
Sector
Market Cap
$7.1B
$51.5M
Price % of 52-Week High
75.38%
57.84%
Dividend Yield
0%
0%
Shareholder Yield
-3%
--
1-Year Price Total Return
-12.36%
-15.08%
Beta (5-Year)
--
0.657
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $23.88
200-day SMA
Buy
Level $21.37
Bollinger Bands (100)
Buy
Level 17.95 - 21.71
Chaikin Money Flow
Sell
Level -73.3M
20-day SMA
Buy
Level $22.51
Relative Strength Index (RSI14)
Buy
Level 72.36
ADX Line
Buy
Level 34.9
Williams %R
Sell
Level -5.0972
50-day SMA
Buy
Level $20.63
MACD (12, 26)
Buy
Level 1.01
25-day Aroon Oscillator
Buy
Level 40
On Balance Volume
Neutral
Level 225.2M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (28.9542)
Buy
CA Score (Annual)
Level (1.1711)
Sell
Beneish M-Score (Annual)
Level (0.4357)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-3.5392)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (7)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Clearwater Analytics Holdings, Inc. engages in the provision of web-based investment portfolio accounting, reporting, and reconciliation services. It operates through the United States and Rest of World geographical segments. Its products include automated data aggregation and validation, investment accounting, integrated reporting tools, a user-friendly solution, and business-specific tools. The company was founded in 2004 and is headquartered in Boise, ID.

Stock Forecast FAQ

In the current month, CWAN has received 2 Buy ratings 5 Hold ratings, and 0 Sell ratings. The CWAN average analyst price target in the past 3 months is $27.89.

  • Where Will Clearwater Analytics Holdings, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Clearwater Analytics Holdings, Inc. share price will rise to $27.89 per share over the next 12 months.

  • What Do Analysts Say About Clearwater Analytics Holdings, Inc.?

    Analysts are divided on their view about Clearwater Analytics Holdings, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Clearwater Analytics Holdings, Inc. is a Sell and believe this share price will drop from its current level to $24.00.

  • What Is Clearwater Analytics Holdings, Inc.'s Price Target?

    The price target for Clearwater Analytics Holdings, Inc. over the next 1-year time period is forecast to be $27.89 according to 7 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 5 analysts rate the stock a Hold.

  • Is CWAN A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Clearwater Analytics Holdings, Inc. is a Hold. 5 of 7 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of CWAN?

    You can purchase shares of Clearwater Analytics Holdings, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Clearwater Analytics Holdings, Inc. shares.

  • What Is The Clearwater Analytics Holdings, Inc. Share Price Today?

    Clearwater Analytics Holdings, Inc. was last trading at $24.16 per share. This represents the most recent stock quote for Clearwater Analytics Holdings, Inc.. Yesterday, Clearwater Analytics Holdings, Inc. closed at $24.12 per share.

  • How To Buy Clearwater Analytics Holdings, Inc. Stock Online?

    In order to purchase Clearwater Analytics Holdings, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.11% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.83% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 9.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock